Related Experiment Videos
[HIV-associated lung diseases]
1Abteilung für Infektiologie, Universitätskliniken Basel.
Abstract:
Over two-thirds of all HIV-infected individuals have an associated pulmonary disease. The following causes are frequently observed: bacterial infection (Streptococcus pneumoniae, Haemophilus influenzae and mycobacteria), protozoal infection (Pneumocystis carinii), fungal infection (Cryptococcus neoformans and Histoplasma capsulatum), viral infection (cytomegalovirus), tumors (Kaposi's sarcoma) and pneumonitis. For diagnosis and patients' immune status, imaging techniques, and microbiological, cytological and histological examination of respiratory secretions and biopsy material are important. Infection with Pneumocystis carinii remains common as a cause of respiratory disease in HIV-infected patients, mainly those without prophylaxis. The clinical presentation of pulmonary tuberculosis varies with the state of immunity. Kaposi's sarcoma is the commonest HIV-associated malignancy, and may affect the lungs in addition to the skin.
Insights
Over two-thirds of individuals with human immunodeficiency virus (HIV) develop pulmonary disease. Common causes include bacterial, protozoal, fungal, and viral infections, alongside tumors like Kaposi's sarcoma.
Area of Science:
- Pulmonology
- Infectious Diseases
- Oncology
Context:
- Over 66% of individuals with human immunodeficiency virus (HIV) experience associated pulmonary diseases.
- Pulmonary complications significantly impact morbidity and mortality in HIV-infected populations.
- Understanding these conditions is crucial for managing HIV patients.
Purpose:
- To review the spectrum of pulmonary diseases in HIV-infected individuals.
- To highlight common causative agents and diagnostic modalities.
- To emphasize the importance of early diagnosis and management.
Summary:
- Common causes of pulmonary disease in HIV patients include bacterial infections (e.g., Streptococcus pneumoniae, Mycobacterium tuberculosis), protozoal infections (Pneumocystis carinii), fungal infections (Cryptococcus neoformans, Histoplasma capsulatum), viral infections (cytomegalovirus), and malignancies (Kaposi's sarcoma).
- Diagnostic approaches involve imaging techniques and microbiological, cytological, and histological examinations of respiratory samples and biopsy tissues.
- Pneumocystis carinii pneumonia remains prevalent, particularly in patients without prophylaxis, and the presentation of pulmonary tuberculosis is often linked to the patient's immune status.
Impact:
- Improved diagnostic strategies for pulmonary diseases in HIV patients.
- Enhanced understanding of the diverse range of lung pathologies associated with HIV.
- Potential for better patient outcomes through timely and accurate diagnosis and treatment of pulmonary complications.